Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Theratechnologies Stock Quote

Theratechnologies (TSX: TH)

CA$1.85
(-2.1%)
-CA$0.04
Price as of April 24, 2024, 3:59 p.m. ET

Theratechnologies Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
TH -62.40% -93.25% -41.67% -91%
S&P +22.56% +73.28% +11.62% +990%

Theratechnologies Company Info

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.